An article published early online and in the December edition of The Lancet Oncology reports that if breast cancer patients who receive endocrine treatment develop hot flushes, vasomotor symptoms (such as cold and night sweats), and joint symptoms, then they have a lower likelihood of cancer recurrence. That is, the toxicity of the treatment is acting as an indicator of treatment success.
More...